ES2161247T3 - Preparacion vaginal que contiene un peptido fisiologicamente activo. - Google Patents
Preparacion vaginal que contiene un peptido fisiologicamente activo.Info
- Publication number
- ES2161247T3 ES2161247T3 ES94917146T ES94917146T ES2161247T3 ES 2161247 T3 ES2161247 T3 ES 2161247T3 ES 94917146 T ES94917146 T ES 94917146T ES 94917146 T ES94917146 T ES 94917146T ES 2161247 T3 ES2161247 T3 ES 2161247T3
- Authority
- ES
- Spain
- Prior art keywords
- physiologically active
- active peptide
- preparation containing
- vaginal preparation
- vaginal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000001976 improved effect Effects 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
UNA PREPARACION VAGINAL MEJORADA PARA EFECTUAR UNA ABSORCION EFICIENTE DE UN PEPTIDO ACTIVO FISIOLOGICAMENTE, CARACTERIZADO POR CONTENER UN PEPTIDO ACTIVO FISIOLOGICAMENTE, UN ESTER ACIDO GRASO DE SACAROSA, UN ACIDO ORGANICO, Y UN TRANSPORTADOR FARMACEUTICAMENTE ACEPTABLE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13573893A JP3628713B2 (ja) | 1993-06-07 | 1993-06-07 | 生理学的に活性なペプチドを含有する膣投与製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2161247T3 true ES2161247T3 (es) | 2001-12-01 |
Family
ID=15158721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94917146T Expired - Lifetime ES2161247T3 (es) | 1993-06-07 | 1994-06-02 | Preparacion vaginal que contiene un peptido fisiologicamente activo. |
Country Status (9)
Country | Link |
---|---|
US (2) | US5776886A (es) |
EP (1) | EP0702958B1 (es) |
JP (1) | JP3628713B2 (es) |
KR (1) | KR100419558B1 (es) |
AU (1) | AU6856194A (es) |
CA (1) | CA2164193C (es) |
DE (1) | DE69427977T2 (es) |
ES (1) | ES2161247T3 (es) |
WO (1) | WO1994028918A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3628713B2 (ja) * | 1993-06-07 | 2005-03-16 | 帝國製薬株式会社 | 生理学的に活性なペプチドを含有する膣投与製剤 |
US8765177B2 (en) * | 1997-09-12 | 2014-07-01 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
US7153845B2 (en) * | 1998-08-25 | 2006-12-26 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
US7402559B2 (en) | 1999-03-24 | 2008-07-22 | Msh Pharma, Incorporated | Composition and method of treatment for urogenital conditions |
CN1183965C (zh) | 2000-02-04 | 2005-01-12 | 尤尼金实验室公司 | 鼻内降钙素制剂 |
AT409081B (de) * | 2000-02-16 | 2002-05-27 | Gebro Pharma Gmbh | Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung |
AU2003269747A1 (en) * | 2002-05-15 | 2003-12-02 | Sun Pharmaceutical Industries Limited | A stable aqueous composition of a peptide |
DE10248412B4 (de) * | 2002-08-01 | 2009-05-20 | Bernd Rauscher | Suppositorium zur Behandlung oder Vorbeugung von Hypoglykämie |
DE60332483D1 (de) | 2002-11-15 | 2010-06-17 | Novartis Vaccines & Diagnostic | Methoden zur verhinderung und behandlung von krebs-metastasierung und mit krebs-metastasierung einhergehendem knochenverlust |
CA2566032A1 (en) * | 2004-05-13 | 2005-12-01 | Alza Corporation | Apparatus and method for transdermal delivery of parathyroid hormone agents |
US8088093B2 (en) * | 2008-08-07 | 2012-01-03 | Ottuso Patrick | Wound penetrating hemostatic device impregnated with coagulant, antibiotic and/or anesthetic |
CN102958512B (zh) | 2008-08-29 | 2015-04-29 | 健赞股份有限公司 | 控释肽制剂 |
WO2011103183A1 (en) * | 2010-02-16 | 2011-08-25 | Playtex Products,Llc | Low ph, optimal orp, and odor-reducing fibers, a process for making the fibers, and articles made therefrom |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59148717A (ja) * | 1983-02-11 | 1984-08-25 | Takeda Chem Ind Ltd | 膣投与製剤 |
JPS6210020A (ja) * | 1985-07-08 | 1987-01-19 | Kanebo Ltd | カルシトニン含有組成物 |
JPS62267238A (ja) * | 1986-05-15 | 1987-11-19 | R P Shiila- Kk | インシユリン坐剤の製法 |
JPS6339822A (ja) * | 1986-08-04 | 1988-02-20 | Yamanouchi Pharmaceut Co Ltd | カルシトニン経鼻剤 |
JPH01230530A (ja) * | 1987-11-21 | 1989-09-14 | Toyo Jozo Co Ltd | カルシトニン類経鼻投与用液剤組成物 |
NO179479C (no) * | 1988-03-11 | 1996-10-16 | Teikoku Seiyaku Kk | Fremgangsmåte for fremstilling av et intravaginalt farmasöytisk preparat |
JPH0348627A (ja) * | 1989-07-14 | 1991-03-01 | Kanebo Ltd | カルシトニン腟坐剤 |
JPH0381228A (ja) * | 1989-08-24 | 1991-04-05 | Kanebo Ltd | カルシトニン腟坐剤 |
JPH04149126A (ja) * | 1990-10-09 | 1992-05-22 | Mitsubishi Kasei Corp | 経粘膜投与用医薬組成物 |
CA2070061C (en) * | 1991-06-07 | 2004-02-10 | Shigeyuki Takama | Physiologically active polypeptide-containing pharmaceutical composition |
EP0566135A1 (en) * | 1992-04-17 | 1993-10-20 | Takeda Chemical Industries, Ltd. | Transmucosal composition comprising a peptide and a cytidine derivative |
JP3628713B2 (ja) * | 1993-06-07 | 2005-03-16 | 帝國製薬株式会社 | 生理学的に活性なペプチドを含有する膣投与製剤 |
-
1993
- 1993-06-07 JP JP13573893A patent/JP3628713B2/ja not_active Expired - Fee Related
-
1994
- 1994-06-02 CA CA002164193A patent/CA2164193C/en not_active Expired - Fee Related
- 1994-06-02 KR KR1019950705529A patent/KR100419558B1/ko not_active IP Right Cessation
- 1994-06-02 AU AU68561/94A patent/AU6856194A/en not_active Abandoned
- 1994-06-02 EP EP94917146A patent/EP0702958B1/en not_active Expired - Lifetime
- 1994-06-02 DE DE69427977T patent/DE69427977T2/de not_active Expired - Fee Related
- 1994-06-02 ES ES94917146T patent/ES2161247T3/es not_active Expired - Lifetime
- 1994-06-02 WO PCT/JP1994/000894 patent/WO1994028918A1/ja active IP Right Grant
- 1994-06-02 US US08/557,104 patent/US5776886A/en not_active Expired - Lifetime
-
1998
- 1998-01-21 US US09/009,734 patent/US6008189A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69427977T2 (de) | 2001-11-29 |
JPH06345665A (ja) | 1994-12-20 |
KR100419558B1 (ko) | 2004-05-20 |
DE69427977D1 (de) | 2001-09-20 |
JP3628713B2 (ja) | 2005-03-16 |
US6008189A (en) | 1999-12-28 |
CA2164193A1 (en) | 1994-12-22 |
CA2164193C (en) | 2007-09-18 |
EP0702958A4 (en) | 1996-12-04 |
AU6856194A (en) | 1995-01-03 |
WO1994028918A1 (fr) | 1994-12-22 |
US5776886A (en) | 1998-07-07 |
EP0702958B1 (en) | 2001-08-16 |
EP0702958A1 (en) | 1996-03-27 |
KR960702754A (ko) | 1996-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2161247T3 (es) | Preparacion vaginal que contiene un peptido fisiologicamente activo. | |
ES2061772T3 (es) | Inhalante aerosol que comprende un ester de retinol y/o de acido retinico. | |
ES2103563T3 (es) | Esteres nitricos con una actividad farmacologica y procedimiento para su preparacion. | |
AR048891A2 (es) | Composicion farmaceutica en forma de una solucion para la administracion de inhibidores de proteasa hiv | |
GEP20002013B (en) | Therapeutical Means | |
ES2183841T3 (es) | Formas de dosificacion para administrar un farmasco en una formulacion lquidid. | |
AR013742A1 (es) | Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida | |
MY131796A (en) | Use of glp-1 or analogs in treatment of myocardial infraction | |
ITMI922953A1 (it) | Inibitori a doppia attivita' biologica di no sintasi e cicloossigenasi procedimento per la loro preparazione e composizioni terapeutiche che li contengono. | |
AR079399A2 (es) | Procedimientos para preparar bifenazato | |
NO931831L (no) | Farmas!ytiske blandinger | |
DK0600544T3 (da) | Anvendelse af lycopen til at reducere aktivitet af celler, især af cancerceller, og farmaceutiske præparater | |
ES2181165T3 (es) | Uso de un peptido asociado a la latencia para la preparacion de un medicamento para aumentar la curacion de heridas. | |
PA8451701A1 (es) | Formulacion inyectable transparente de compuesto anestesico | |
IT1170214B (it) | Composizione farmaceutica per la cura delle arteriopatie periferiche | |
DK1383540T3 (da) | Fremgangsmdåer og farmaceutiske sammensætninger til sårheling | |
PT95697A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo substancias antiandrogenicamente activas | |
ES2134237T3 (es) | Composiciones farmaceuticas que contienen acido ursodesoxicolico. | |
ZA978400B (en) | Use of inhibitors of the activity of retinoic acid to promote healing. | |
PT100415A (pt) | Novas morfolinas de accao farmaceutica, e processo para a sua preparacao | |
PT721467E (pt) | Utilizacao de relaxina como analgesico e paliativo para dor refractaria | |
TR199801184T2 (xx) | Analjezik tesirli yeni bile�ikler. | |
KR970704455A (ko) | 인터류킨 5 생성 억제제(Interleukin 5 Production Inhibitor) | |
DE69739482D1 (de) | Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen | |
AR012638A1 (es) | Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 702958 Country of ref document: ES |